Showing results (131-140 of 5,197) with videos related to

Sort By:
Pageof 520
Parkinsonism & Related Disorders|June 7, 2020
Clinical and neuroimaging correlates of progression of mild parkinsonian signs in community-dwelling older adultsCameron Miller-Patterson, Jennifer Han, Kristine Yaffe, et al.
Parkinsonism & Related Disorders|June 7, 2020
The late stage of Parkinson's -results of a large multinational study on motor and non-motor complicationsA Schrag, A L A J Hommel, S Lorenzl, et al.
Parkinsonism & Related Disorders|May 2, 2021
Efficacy results of pimavanserin from a multi-center, open-label extension study in Parkinson's disease psychosis patientsStuart H Isaacson, Clive G Ballard, David L Kreitzman, et al.
Parkinsonism & Related Disorders|May 8, 2021
Comparison in detection of prodromal Parkinson's disease patients using original and updated MDS research criteria in two independent cohortsKristina Kulcsarova, Joaquim Ribeiro Ventosa, Eva Feketeova, et al.
Parkinsonism & Related Disorders|June 4, 2020
Progressive supranuclear palsy: Advances in diagnosis and managementDavid G Coughlin, Irene Litvan
Parkinsonism & Related Disorders|May 29, 2020
Clinical implications of gastric complications on levodopa treatment in Parkinson's diseaseRonald F Pfeiffer, Stuart H Isaacson, Rajesh Pahwa
Parkinsonism & Related Disorders|September 18, 2021
Clinical perception and management of Parkinson's disease during the COVID-19 pandemic: A Canadian experienceAurelie de Rus Jacquet, Sarah Bogard, Catherine P Normandeau, et al.
Parkinsonism & Related Disorders|August 6, 2022
Unraveling Parkinson's disease heterogeneity using subtypes based on multimodal dataFranziska Albrecht, Konstantinos Poulakis, Malin Freidle, et al.
Parkinsonism & Related Disorders|September 16, 2021
Toll-like receptor 4 deficiency facilitates α-synuclein propagation and neurodegeneration in a mouse model of prodromal Parkinson's diseaseSerena Venezia, Walter A Kaufmann, Gregor K Wenning, et al.
Parkinsonism & Related Disorders|September 11, 2021
Fasting state is one of the factors associated with plasma levodopa fluctuations during levodopa‒carbidopa intestinal gel treatmentNoriyuki Miyaue, Yuko Hosokawa, Akira Yoshida, et al.
Pageof 520